10/28/2020 6:18:17 AM
Absolute Announces Pricing Of $60 Mln Public Offering Of Common Shares
10/26/2020 7:25:35 AM
Absolute Software Expects Sept. Quarter Revenue To Be $28.5 Mln, Net Income To Be $2.6 Mln
10/21/2020 7:31:40 AM
Abbott Q3 Reported EPS From Cont Ops $0.69 Vs $0.53 Last Year
10/19/2020 3:16:59 PM
Absolute Declares Quarterly Dividend Of C$0.08/share, Payable Nov. 30/ Record Nov. 13
10/12/2020 9:01:54 AM
Abbott Gets FDA Emergency Use Authorization For COVID-19 IgM Antibody Blood Test
10/7/2020 8:04:46 AM
Abbott Releases New Interim Clinical Data Results On Its ID NOW COVID-19 Rapid Test
9/28/2020 9:03:32 AM
Abbott's FreeStyle Libre 3 System Receives CE Mark
9/21/2020 9:05:14 AM
Abbott Gets CE Mark For Next-Generation MitraClip Heart Valve Repair Device To Treat Mitral Regurgitation
9/17/2020 12:00:36 PM
Abbott Declares Quarterly Dividend Of $0.36/share, Payable No. 16/ Record Oct. 15
9/17/2020 11:50:41 AM
Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.36, Record Date 10/15/2020
9/17/2020 9:07:15 AM
Abbott Introduces Libre Sense Glucose Sport Biosensor In Europe
9/9/2020 8:07:02 AM
Absolute Announces Limited-time Offers For Customers To Purchase Critical Add-on Capabilities
9/3/2020 9:01:42 AM
Abbott Announces Start Of LIFE-BTK Clinical Trial
9/1/2020 9:03:36 AM
Abbott Makes Available FreeStyle Libre 2 ICGM System To Medicare Beneficiaries